newswire

Johnson & Johnson's OTTAVA™ robotic surgical system has received marketing approval from the US FDA

2026-07-22·newswire-us-stock-125149

Johnson & Johnson's OTTAVA™ robotic surgical system has received marketing approval from the US FDA.

China Financial News Agency reported on July 22 that Johnson & Johnson's OTTAVA™ robotic surgical system has received marketing approval from the US FDA.

#Stocks #IPO

Full text

Johnson & Johnson's OTTAVA™ robotic surgical system has received marketing approval from the US FDA

China Financial News Agency reported on July 22 that Johnson & Johnson's OTTAVA™ robotic surgical system has received marketing approval from the US FDA.

← Back to archive